Chief Financial Officer
Wed, Dec 10, 2025
Dec 10
exercised or converted securities in PCRX
9,104 shares @ $0.00
Decreased holdings by -4.90%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+2.95%
1M-7.55%
3M-1.79%
6M—
1Y—